Voltage-dependent anion channels (VDACs) are expressed in three isoforms, with common channeling properties and different roles in cell survival. We show that VDAC1 silencing potentiates apoptotic challenges, whereas VDAC2 has the opposite effect. Although all three VDAC isoforms are equivalent in allowing mitochondrial Ca 2 þ loading upon agonist stimulation, VDAC1 silencing selectively impairs the transfer of the low-amplitude apoptotic Ca 2 þ signals. Co-immunoprecipitation experiments show that VDAC1, but not VDAC2 and VDAC3, forms complexes with IP 3 receptors, an interaction that is further strengthened by apoptotic stimuli. These data highlight a non-redundant molecular route for transferring Ca 2 þ signals to mitochondria in apoptosis.
Voltage-dependent anion channels (VDACs), the most abundant proteins of the outer mitochondrial membrane (OMM), mediate the exchange of ions and metabolites between the cytoplasm and mitochondria, and are key factors in many cellular processes, ranging from metabolism regulation to cell death. VDACs are high-conductance, weakly anion-selective channel, fully open at low potential, but switching to cation selectivity and lower conductance at higher potentials ('closed' state). Multicellular organisms and mammals have three distinct VDAC genes (VDAC1, VDAC2 and VDAC3), with high sequence homology and similar structure. The recently solved 3D-structure of VDAC1 [1] [2] [3] shows a b-barrel membrane protein composed of 19 b-strands with a regulatory a-helix N-terminal domain residing inside the pore.
Besides its fundamental role as metabolite exchanger, the pleiotropic role of VDACs appears to rely on their ability to engage protein-protein interactions with different partners. Indeed, VDACs have been shown to interact with cytoskeletal elements such as actin and tubulin, 4 ,5 metabolic enzymes, 6 Bcl2-family members including Bak, 7 Bad, 8 tBid 9 and Bcl-xL 10 or other channels such as ANT, 11 or the IP 3 R. 12, 13 This scenario is further complicated by evidence showing that VDAC contribution to cell death can be isoform and stimulus dependent: VDAC1 acts predominantly as a pro-apoptotic protein [14] [15] [16] [17] whereas VDAC2 protects from a number of apoptosis inducers, 18 but concurrently appears to be necessary for tBid-mediated cell-death. 9 However, these different effects are not supported by the apparent redundancy in the electrophysiological properties of the isoforms. 19, 20 Mitochondrial [Ca 2 þ ] is commonly regarded as an important determinant in cell sensitivity to apoptotic stimuli. 21 Indeed, mitochondrial Ca 2 þ accumulation acts as a 'priming signal' sensitizing the organelle and promoting the release of caspase cofactors, both in isolated mitochondria as well as in intact cells. 22, 23 In this context, ER-mitochondria contacts mediate the tight and efficient Ca 2 þ transmission between the two organelles and thus could represent a potential regulatory site for cell death signals. 24 Here we investigate the role of the different VDAC isoforms in the context of cell sensitivity to apoptosis and their role in regulating ER-mitochondrial Ca 2 þ signals transmission, and demonstrated that VDAC1, by selectively interacting with the IP 3 Rs, is preferentially involved in the transmission of the low-amplitude apoptotic Ca 2 þ signals to mitochondria.
Results
In this work, we aimed to correlate the Ca 2 þ channeling properties of the VDAC isoforms with their effects on cell death. We first downregulated the individual isoforms by RNAi silencing (Figure 1c ). The siRNA of interest was cotransfected with a GFP reporter, and the effect on cell fate was evaluated by applying an apoptotic challenge (C2-ceramide or H 2 O 2 ) and comparing the survival of transfected and non-transfected cells. In these experiments, the siRNA of interest was co-transfected with a GFP reporter and the percentage of GFP-positive cells was calculated before and after applying an apoptotic stimulus (C2-ceramide or H 2 O 2 ). In mock-transfected cells, although the total number of cells is reduced after cell death induction, the apparent transfection efficiency was maintained (i.e. transfected and non-transfected cells have the same sensitivity to the apoptotic stimulus and thus die to the same extent). However, when GFP-positive cells are co-transfected with a construct influencing their sensitivity to apoptosis, this will be reflected by a change in the fraction of fluorescent cells, that is, in the 'apparent' transfection efficiency. Thus, protection from apoptosis results into an apparent increase of transfection, whereas a decrease reflects a higher sensitivity to apoptosis. The results of the experiment are shown in Figure 1 . Mocktransfected cells show no difference in the percentage of fluorescent cells after H 2 O 2 treatment (À3.7 ± 5.2%), whereas in the same conditions VDAC1-, VDAC2-and VDAC3-silenced GFP-positive cells were varied by 20±4.1%, À44.4 ± 6.8% and 4.7 ± 3.1%, respectively (Figure 1a) . Similar results were obtained with C2-ceramide (Figure 1b) . This confirms the notion that VDAC1 is pro-apoptotic and, among the various reported effects of VDAC2, the pro-survival role is prevailing in HeLa cells. Finally, VDAC3 shows no significant effect on apoptosis.
Considering that the enhancement of mitochondrial Ca 2 þ uptake generally correlates with increased sensitivity to apoptosis 21 and that VDAC1 has been shown to be a regulator of OMM permeability to Ca 2 þ , 15 we wondered whether isoform specificity could rely on different Ca 2 þ channeling properties of the VDACs. The individual VDAC siRNAs were thus co-transfected with a mitochondrial Ca 2 þ -probe (mtAeqMut). After aequorin reconstitution with the cofactor coelenterazine, cells were challenged with 100 mM histamine, and luminescence was measured and converted to (Figure 3a) , nor of its release kinetics (data not shown). Accordingly, the cytosolic [Ca 2 þ ] transient evoked by histamine stimulation was not significantly affected when any isoform were silenced (Figure 3b ) or overexpressed (Figure 3c ). Finally, mtGFP imaging and mitochondrial loading with the potential sensitive dye tetramethylrhodamine methyl ester (TMRM) showed that the effect was not due to changes in mitochondrial morphology or significant reduction of mitochondrial membrane potential (data not shown). Altogether, these data, while showing a clear effect of VDAC silencing or overexpression on mitochondrial Ca 2 þ handling, argue against the possibility that the pro-apoptotic effect of VDAC1 depends on a greater Ca 2 þ conductance of this isoform. Rather, the data may suggest a preferential role of the VDAC2 and VDAC3 isoforms in Ca 2 þ transport (also considering their lower expression levels 25 ), although the real significance of this observation could be hampered by differences in protein stability or trafficking to the OMM.
The pro-apoptotic activity of VDAC1 thus appears either totally independent of Ca 2 þ , or due to the fine tuning of Ca 2 þ signals in specialized microdomains that may be overlooked in bulk cytosolic measurements. 26 We followed the latter
Figure 1
Sensitivity to apoptotic challenges of VDAC-silenced cells. Cells were co-transfected with a fluorescent marker (GFP) and the siRNA of interest. The graph bar shows the change in percentage of fluorescent cells before the treatment with 100 mM H 2 O 2 for 2 h ((a) control À3.7 ± 5.2%; siRNA-hVDAC1 20 ± 4.1%; siRNA-hVDAC2 À44.4 ± 6.8%; siRNA-hVDAC3 þ 4.7 ± 3.1%) and 30 mM C2-ceramide for 2 h ((b) control À4 ± 5.3%; siRNA-hVDAC1 þ 24.3 ± 5.1%; siRNA-hVDAC2 À50.1 ± 6.8%; siRNA-hVDAC3 þ 7.1 ± 2.5%). (c) HeLa cells were transfected for 48 h with control or siRNA-hVDAC encoding plasmid. Cells were harvested, total protein was extracted and subjected to western blotting analysis with antibodies anti-b-tubulin as loading control and anti-VDAC specific antibodies as indicated possibility, based on growing evidence demonstrating that the mitochondria/ER crosstalk is not merely the consequence of physical neighborhood but relies on the existence of macromolecular complexes linking the two organelles. 27, 28 Specifically, during massive Ca 2 þ release upon maximal agonist stimulation, the existence of discrete signaling units could be overwhelmed and masked by the robustness of the response. Conversely, when an apoptotic stimulus causes a small, sustained Ca 2 þ release the existence of preferential channeling routes could become relevant. Based on previous data, showing the interaction of the IP 3 R with VDAC mediated by the grp75 chaperone, 12 we investigated whether IP 3 Rs and grp75 preferentially interact with VDAC1, forming privileged signaling units. We first performed co-immunoprecipitation experiments using the highly expressed IP 3 R type 3 (IP 3 R-3) as bait. Strikingly, Figure 4a shows that VDAC1 is the only isoform bound to the IP 3 R in stringent conditions: no VDAC2 or VDAC 3 could be detected, also in long-term exposures. Neither actin, nor hexokinase-I, a known interactor of VDAC1, were co-immunoprecipitated in the assay, whereas the grp75 chaperone did. To confirm the specificity of the interaction, we also carried out the reverse experiment, by immunoprecipitating VDAC1 and revealing the presence of grp75 and IP 3 R-3 in the precipitate. In these experiments, the cells were transfected with an HA-tagged VDAC1 fusion protein, and immunoprecipitation was carried out with anti-HA antibodies. The results, shown in Figure 4b , demonstrate that both IP 3 R-3 and grp75 co-immunoprecipitate with VDAC1 (similarly to previous data with the IP 3 R-1, 12 and see also Figure 5c ). We then investigated whether the VDAC1-IP 3 Rs interaction is altered in apoptotic conditions. We thus performed coimmunoprecipitations in cells challenged with H 2 O 2 using grp75 or VDAC1-HA as bait. VDAC1 pull-down in H 2 O 2 -treated cells resulted in a significantly greater amount of both grp75 and IP 3 R in the immunoprecipitate (Figure 5a ), and the relative amount of IP 3 R co-immunoprecipitating with grp75 was significantly greater in H 2 O 2 -treated cells (Figure 5b ). Moreover, we performed co-immunoprecipitation experiments also with IP 3 R type 1: as shown in Figure 5c , similarly to IP 3 R-3, also IP 3 R-1 interacts with VDAC1 but not with VDAC2, and H 2 O 2 treatment enhance this interaction (although the effect seems weaker than with IP 3 R-3).
Figure 2
Effect of VDAC isoform silencing or overexpression on mitochondrial Ca 2 þ uptake. (Figures 6a and b) . Under those conditions, mitochondria also undergo a small increase (peak value o1 mM). VDAC1 silencing decreased mitochondrial Ca 2 þ accumulation, while the knock-down of the other isoforms was indistinguishable from controls. We then titrated the histamine concentration in order to elicit a small Ca 2 þ response, comparable to that evoked by H 2 O 2 by applying a 0.5 mM histamine challenge. Under those conditions, no difference among the different VDAC isoforms could be revealed (Figure 6c ), thus suggesting that besides the slow kinetics the strengthening of the physical coupling of the IP 3 R and VDAC1 channels by apoptotic challenges may have an important role in the potentiation of mitochondrial Ca 2 þ signals and the induction of cell death.
Finally, in order to dissect the precise contribution of the different IP 3 R isoforms to the VDAC1-dependent transmission of apoptotic challenges, we investigated the effect of shRNAs against IP 3 R type 1 and 3. We first screened a panel of shRNAs, selecting for further studies the two shRNAs (shIP 3 R-1#58 and shIP 3 R-3#67) that gave 450% reduction in IP 3 R-1 and IP 3 R-3 protein levels, respectively (Figure 7a ). We thus tested cellular sensitivity to apoptotic stimuli by carrying out the experiment of Figure 1 in the cells in which IP 3 Rs were selectively silenced. Strikingly, while IP 3 R-1 silencing seems to have no consequence on cell death induced by H 2 O 2 , silencing of the IP 3 R-3 almost abrogated the protective effect of VDAC1 silencing, thus further demonstrating that IP 3 R-3 and VDAC1 act on the same signaling route.
Figure 4
Co-immunoprecipitations of VDAC1 with IP 3 R-3. Co-immunoprecipitations using IP 3 R-3 (a) and VDAC1-HA (b) as baits. HeLa cells were grown in 10-cm Petri dishes until full confluence. For VDAC1-HA immunoprecipitation, cells were transfected 48 h before experiment. Cells were then detached by scraping, harvested and proteins were extracted in non-denaturing conditions as indicated in the methods section. After protein quantification, 700 mg were incubated overnight at 4 1C with the 3 mg of the indicated antibody. The immunocomplex was then isolated by adding protein G-coated sepharose beads for 2 h at 4 1C. The purified immunocomplex was then washed three times with lysis buffer. Indicated fractions were then subjected to SDS-PAGE and western blotting, and probed with the indicated antibodies
Figure 5
Co-immunoprecipitations of VDAC1 with IP 3 R-3 after H 2 O 2 treatment. Co-immunoprecipitations using VDAC1-HA (a), grp75 (b) and IP 3 R-1 (c) as baits. HeLa cells were grown in 10-cm Petri dishes until full confluence. For VDAC1-HA immunoprecipitation, cells were transfected 48 h before experiment. Cells were then detached by scraping, harvested, incubated for 10 min with vehicle or 1 mM H 2 O 2 and proteins were extracted in non-denaturing conditions as indicated in the methods section. After protein quantification, 700 mg were incubated overnight at 4 1C with the 3 mg of the indicated antibody. The immunocomplex was then isolated by adding protein G-(for anti-HA) or A-(for anti-IP 3 R-1 and grp75) coated sepharose beads for 2 h at 4 1C. The purified immunocomplex was then washed three times with lysis buffer. Indicated fractions were then subjected to SDS-PAGE and western blotting, and probed with the indicated antibodies 
Discussion
Several observations support the notion that VDAC can finely tune cellular processes in an isoform-specific way: (i) selective genetic ablation of the three VDAC genes exhibits different phenotypes; 29 (ii) VDAC1 and VDAC2 exert diametrically opposite effects on apoptosis 15, 16, 18 and a compound acting through VDAC2, erastin, is effective in tumors harboring Ras mutations; 30 (iii) apoptotic challenges 31 and genomic programs, such as the PGC1-a pathway (De Stefani and Rizzuto, unpublished), differentially regulate the expression of VDAC isoforms; and (iv) the three isoforms are localized to different sub-domains of the OMM. 32 We thus investigated in greater detail the molecular mechanism underlying the different role of VDAC isoforms in apoptosis. The first, obvious explanation of this diversity relied on different Ca 2 þ channeling capacities, given the sensitizing role of Ca 2 þ in the release of caspase activators. Our results ruled out the possibility, by showing relatively minor differences in Ca 2 þ channeling that cannot account for their differential cell death regulation. These minor differences could potentially be due to small variations in Ca 2 þ transport capacities. However, as in situ VDAC levels after overexpression or gene silencing are quite difficult to rigorously assess, this conclusion is risky. These data simply support the notion that all VDAC isoforms can similarly transport Ca 2 þ in living cells, and this is not correlated with their effect on apoptosis.
How can we then solve the discrepancy between mitochondrial Ca 2 þ transport and apoptosis regulation? An obvious conclusion is the denial (or, at least the reconsideration) of the classic paradigm linking mitochondrial Ca 2 þ to apoptosis. However, this notion is now supported by broad evidence showing that mitochondrial Ca 2 þ loading favors cell death and signaling molecules reducing or increasing Ca 2 þ signals protect from or enhance apoptosis, respectively. 33 Ca 2 þ in mitochondria, however, is an intrinsically pleiotropic signal, 34 and the final outcome varies widely depending on both the 
À7.5 ± 2.5%; siRNA-hVDAC1 27.4 ± 1.5%; siRNA-hVDAC2 À45.9 ± 3.5%; c, Control À6.5 ± 2.1%; siRNA-hVDAC1 þ 30.9 ± 3.9%; siRNA-hVDAC2 À45.2 ± 2.3%; d, Control À4 ± 5.3%; siRNA-hVDAC1 þ 24.3 ± 5.1%; siRNA-hVDAC2 À50.1 ± 6.8%) 23 This latter event has been proposed to represent a sort of priming signal that conditions and sensitizes mitochondria to otherwise non-lethal stimuli. In this context, the local coupling between ER and mitochondrial Ca 2 þ channels becomes critically relevant: small Ca release. On the ER side, the notion that the accurate discrimination of Ca 2 þ signals mediating diverse effects relies on highly specialized molecular determinants was associated to the observation that the selective knockdown of IP 3 R-3 impairs cell death signals transmission whereas the silencing of the other two isoforms had almost no effect. 35, 36 On the mitochondrial side, we wondered whether a similar selectivity could be associated to the mitochondrial channel repertoire at ER/mitochondria contact sites. The results clearly confirmed this possibility, by demonstrating that VDAC1 is preferentially involved in the transfer of apoptotic stimuli (such as those induced by H 2 O 2 ) rather than physiological responses to agonists. Strikingly, our co-immunoprecipitation studies showed that IP 3 R selectively interacts with VDAC1, providing a molecular route for the higher sensitivity of the Ca 2 þ transfers. Moreover, this selective interaction appears not static but finely tuned by cellular conditions, as demonstrated by the fact that H 2 O 2 strengthens the coupling between the ER and mitochondrial Ca 2 þ channels, and by the selective involvement of VDAC1 in the transmission of apoptotic stimuli. Although our biochemical evidences suggest that all IP 3 R isoforms are dynamically involved in this process (i.e., both IP 3 R-1 and IP 3 R-3 selectively interacts with VDAC1), functional data suggest a preferential role of the IP 3 R-3 in the transmission of apoptotic stimuli, in agreement with previous reports. Moreover, our data also suggest that the mechanism of the protective effect of VDAC2 on cell death does not involve the transmission of Ca 2 þ signals. Overall, the data presented in this paper reveal a complex molecular organization underlying VDAC Ca 2 þ channeling properties, and allowing VDAC1 to exert its pro-apoptotic activity. The emerging picture reveals that VDACs represent a fundamental factor in mitochondria physiology, with similar channeling properties shared among its different variants, but also mediating diverse effects through isoform-specific protein-protein interactions and the assembly of highly specialized, higher-order protein complexes. This view accounts for most of experimental data available and finally reconciles apparently contrasting evidence, allowing a deeper insight on mitochondrial regulation of cell life and death.
Materials and Methods Materials. Antibodies were purchased from the following sources and used at the indicated dilutions: aVDAC1 from Calbiochem (Darmstadt, Germany; 1 : 10 000) and AbNova (Taipei, Taiwan; 1 : 2000); aVDAC2 (1 : 1000), aVDAC3 (1 : 1000) and aIP 3 R-1 (1 : 1000) from Abcam (Cambridge, UK); aIP3R-3 (1 : 1000) from BD Biosciences (San Jose, CA, USA); atubulin (1 : 10 000), aactin (1 : 5000) and aHA (1 : 5000) from Sigma-Aldrich (St. Louis, MO, USA); aHK-I (1 : 1000) and agrp75 (1 : 10 000) from Santa Cruz (Santa Cruz, CA, USA). TMRM was purchased from Invitrogen (Carlsbad, CA, USA). All other chemicals were purchased from Sigma-Aldrich.
Cell culture and transfection. In all the experiments HeLa cells were used. Cells were grown in Dulbecco's modified Eagle's medium (Euroclone, Milan, Italy), supplemented with 10% fetal bovine serum (Euroclone) and transfected with a standard calcium-phosphate procedure. For aequorin measurements, the cells were seeded 24 h before transfection onto 13-mm glass coverslips and allowed to grow to 50% confluence before transfection. For cell death experiments, cells were seeded onto 12-well plates 24 h before transfection. For western blot and co-immunoprecipitation experiments cells were grown in 10-cm Petri dishes.
Plasmid cloning. For selective VDAC silencing several sequences were cloned and tested for specific silencing efficiency without upregulation of the other isoforms. The most effective sequences were: 5 0 -AAGCGGGAGCACATTAACCTG-3 0 for hVDAC1; 5 0 -AAGGATGATCTCAACAAGAGC-3 0 for hVDAC2; 5 0 -AAGGGTGGCTTG CTGGCTATC-3 0 for hVDAC3. Appropriate oligonucleotides containing the selected sequences were purchased from Sigma-Aldrich and cloned into pSuper (Oligoengine, Seattle, WA, USA) according to manufacturer's instructions. VDAC-YFP isoforms have been cloned in a pEGFP-C3 (Clontech, Palo Alto, CA, USA) mutated to obtain the YFP. hVDAC2 and hVDAC3 have been subcloned EcoRI/SalI into this modified pEYFP-C3 vector from pQE-30 (Qiagen, Hilden, Germany) constructs. hVDAC1 has been directly subcloned BamHI/XhoI into pEYFP-C3. shRNA constructs against IP 3 Rs were obtained by using the BLOCK-iT RNAi Express system from Invitrogen. Four different sequences were chosen for both IP 3 R-1 (miR RNAi Select codes: Hmi409056, Hmi409057, Hmi409058 and Hmi409059) and IP 3 R-3 (miR RNAi Select codes: Hmi409064, Hmi409065, Hmi409066, and Hmi409067), and cloned into pcDNA6.2-GW/EmGFP-miR vectors following manufacturer's instructions.
Dynamic in vivo [Ca 2 þ ] measurements with targeted aequorin probes. cytAeq-, mtAeqMut-, mtAeqwt-or erAeqMut-expressing cells were reconstituted with coelenterazine for 2 h, transferred to the perfusion chamber where light signal was collected in a purpose-built luminometer and calibrated into [Ca 2 þ ] values as previously described. 37 All aequorin measurements were carried out in Krebs-Ringer modified buffer (KRB: 135 mM NaCl, 5 mM KCl, 1 mM MgSO 4 , 0.4 mM K 2 HPO 4 , 1 mM CaCl 2 , 5.5 mM glucose, 20 mM HEPES, pH ¼ 7.4) containing 1 mM CaCl 2 . In the measurement of H 2 O 2 -induced [Ca 2 þ ] changes, the high affinity aequorin variant (mtAeqwt) was used and aequorin reconstitution protocol was slightly modified to avoid photon emission due to the direct oxidation of coelenterazine by H 2 O 2 ; cells were reconstituted with coelenterazine for 1 h, washed three times with KRB supplemented with 2% bovine serum albumin and then incubated in KRB/Ca 2 þ for an additional hour. For [Ca 2 þ ] ER measurements, erAEQmut-transfected cells were reconstituted with coelenterazine n, following ER Ca 2 þ depletion in a solution containing 0 [Ca 2 þ ], 500 mM EGTA, 1 mM ionomycin, as previously described. After three washes with KRB supplemented with 2% bovine serum albumin and 1 mM EGTA, cells were perfused with KRB buffer containing 100 mM EGTA. ER refilling was then triggered by perfusing KRB buffer supplemented with 1 mM CaCl 2 until equilibrium (steady state) was reached.
Co-immunoprecipitation. Co-immunoprecipitations were carried out by using protein A-or protein G-coated sepharose beads (GE Healthcare, Chalfont St. Giles, UK) following manufacturer's instructions. Different protein extraction buffers were used in order to minimize non-specific binding while maximizing antigen extraction. IP 3 R-3 and IP 3 R-1 were extracted in a modified RIPA buffer (150 mM NaCl, 1% NP-40, 0.05% SDS, Tris 50 mM, pH ¼ 8) while HA and grp75 were purified in a NP-40 buffer (150 mM NaCl, 1% NP-40, Tris 50 mM, pH ¼ 8), all supplemented with proteases and phosphatases inhibitors (PMSF, complete Protease Inhibitor Cocktail Tablets and PhosSTOP Phosphatase Inhibitor Cocktail Tablets from Roche, Basel, Switzerland). Extracted proteins (700 mg) were first precleared by incubating lysates with sepharose beads for 1 h at 4 1C and the supernatant (referred as Input) was incubated overnight with the antibody at 4 1C. Precipitation of the immune complexes was carried for 2 h at 4 1C and washed three times with the extraction buffer. Fractions were analyzed through standard SDS-PAGE (NuPage 4-12% Bis-Tris Gel, Invitrogen) and western blot techniques. Cell death experiment. Cell sensitivity to apoptotic stimuli was evaluated as previously described. 24 HeLa cells grown on 12-well plates at 30% confluence were co-transfected with GFP and control or siRNA-hVDACs containing plasmids in a 1 : 1 ratio. For the experiments shown in Figure 7 , siRNA-hVDACs plasmids were co-transfected with plasmids encoding both an EmGFP and the shRNA of interest (either Scrambled, IP 3 R-1 or IP 3 R-3). The effect on cell fate was evaluated by applying an apoptotic challenge (20 mM C2-ceramide or 100 mM H 2 O 2 ) and comparing the survival of transfected and non-transfected cells. In these experiments, the percentage of GFP-positive cells was calculated before and after applying an apoptotic stimulus (C2-ceramide or H 2 O 2 ). In mock-transfected cells, although the total number of cells is reduced after cell death induction, the apparent transfection efficiency was maintained (i.e., transfected and nontransfected cells have the same sensitivity to the apoptotic stimulus and thus die to the same extent). However, when cells are transfected with a construct influencing their sensitivity to apoptosis, this will be reflected by a change in the fraction of fluorescent cells, that is, in the 'apparent' transfection efficiency. Thus, protection from apoptosis results into an apparent increase of transfection, whereas a decrease reflects a higher sensitivity to apoptosis. Data are reported as the mean percentage change in the apparent transfection efficiency after apoptotic challenge compared with vehicle-treated cells. Cells were extensively washed with PBS, stained with DAPI, and two images per field (blue and green fluorescence) were taken at Â 10 magnification (mean transfection efficiency were roughly 30% for all conditions). At least 10 fields per coverslip were randomly imaged and counted. Data presented are the sum of at least two different wells per experimental condition carried out in three different independent experiments. Statistical analysis. Statistical analyses were performed using Student's t-test. A P-value r0.05 was considered significant. All data are reported as means ± S.E.M.
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